Cogent Biosciences, Inc. (COGT) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors - Slideshow (NASDAQ:COGT) 2025-11-10
Cogent BiosciencesCogent Biosciences(US:COGT) Seeking Alpha·2025-11-10 18:32

Group 1 - The article does not provide any specific content related to a company or industry [1]